$100 Million - Follow-OnJoint Bookrunner
Alder BioPharmaceuticals Inc.
$144 Million - Follow-OnJoint Bookrunner
Orexigen Therapeutics, Inc.
$185 Million - Acquisition of US Contrave Rights from TakedaExclusive Financial Advisor
Managed Care / Solid 4Q; Attractive Fundamentals; Macro-Defensive With Deal Close Upside
GILD / Hungry Like the Wolf – Reinitiating Outperform, PT $125
Healthcare IT & Distribution / 2015 PBM Survey – Retail Preferred, CVS Best Positioned for 2017